Journals / Viral Hepatitis Journal / 2012 / Cilt: 18 - Sayı: 1

Seroprevalence of HAV, HBV, HCV and HIV in People Admitted to Batman State Hospital

Batman Devlet Hastanesine Başvuran Kişilerde Hepatit ve HIV Serolojisinin Sonuçları

Pages
6–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion; despite the relatively lower rate of HIV seropositivity, hepatitis viruses, particularly HBV remains to be a significant health problem in our province.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: At the present time viral hepatitis and HIV infection are important global health problems.
📊
Key Findings & Data:The aim of this study was to investigate the rates of HAV, HBV, HCV and HIV seropositivity in people those admitted to Batman State Hospital between Macrh 2010 and March 2011.
💡
Conclusion & Impact:Conclusion: In conclusion; despite the relatively lower rate of HIV seropositivity, hepatitis viruses, particularly HBV remains to be a significant health problem in our province.
🔬Design:Research Article
📍Scope:2010 · 10957 samples
⚙️Variables:Domain Parameters

Abstract

Objective: At the present time viral hepatitis and HIV infection are important global health problems. The aim of this study was to investigate the rates of HAV, HBV, HCV and HIV seropositivity in people those admitted to Batman State Hospital between Macrh 2010 and March 2011. Materials and Methods: Blood samples were searched for HAV IgG, HBsAg, AntiHBs, Anti-HCV and Anti-HIV with CMIA (Chemiluminescent Microparticle Immunoassay) method (Architect İ2000 SR, USA). Results: For anti-HBs, 10957 samples were analyzed and 5266 (48.06%) of these samples were positive. For anti-HCV 9666 samples were analyzed and 186 (1.9%) of these samples were positive. For HAV IgG 2606 samples were analyzed and 2447 (93.9%) of these samples were positive. For anti-HIV 1/2 6442 samples were analyzed and only 1 sample was positive (0.015%). Conclusion: In conclusion; despite the relatively lower rate of HIV seropositivity, hepatitis viruses, particularly HBV remains to be a significant health problem in our province. Effective vaccination coverage and public awareness about infection control measures would be expected to decrease the emergence of new cases. (Viral Hepatitis Journal 2012; 18(1): 6-10)

Özet

Amaç: Günümüzde viral hepatitler ve HIV enfeksiyonu önemli küresel sağlık sorunlarıdır. Bu çalışma, 3 Mart 2010 ve 8 Mart 2011 tarihleri arasında Batman Bölge Hastanesi polikliniklerine başvuran bireylerde; HAV IgG, HBsAg, anti-HBs, anti-HCV ve anti-HIV seropozitiflik oranlarının belirlenmesi amacı ile yapılmıştır. Gereç ve Yöntemler: Alınan kan örnekleri CMIA (Chemiluminescent Microparticle İmmunoassay) yöntemi ile (Architect İ2000 SR, USA) çalışılmıştır. Bulgular: HBsAg açısından incelenen 11131 serum örneğinin 1398’inde (%12,6) HBsAg pozitifliği, anti-HBs açısından incelenen 10957 serum örneğinin 5266’sında (%48,06) anti-HBs pozitifliği, anti-HCV açısından incelenen 9666 örneğin 186’sında (%1,9) anti-HCV pozitifliği, HAV IgG açısından incelenen 2606 örneğin 2447’sinde (%93,9) HAV IgG pozitifliği, anti-HIV 1/2 açısından incelenen 6442 örneğin sadece 1’inde (%0,015) anti-HIV pozitifliği saptanmıştır. Sonuç: Sonuç olarak, viral hepatitler ilimiz için önemli sağlık problemleridir. Aşılama, enfeksiyon kontrol programları ve halkın eğitimi yeni enfeksiyonların riskini azaltabilir. Anti-HIV pozitifliği ilimizde çok düşük bulunmuştur. (Viral Hepatit Dergisi 2012; 18(1): 6-10)

🔖

Cite This Article

DEMİRPENÇE, Ö., IŞIK, S. T., DEĞİRMEN, E., MERT, D., GÜMÜŞ, A., ÇELEN, M. K. (2012). Seroprevalence of HAV, HBV, HCV and HIV in People Admitted to Batman State Hospital. Viral Hepatitis Journal, Cilt: 18 - Sayı: 1, 6–10. https://ajindex.com/articles/332780

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Mann J, Roberts M. Modelling the epidemiology of hepatitis B in New Zealand. J Theor Biol. 2011; 269: 266-72. Epub 2010 Oct 30
  2. Riaz M, Idrees M, Kanwal H, Kabir F. An overview of Triple infection with Hepatitis B, C and D viruses. Virol J. 2011; 8: 368
  3. Walter SR, Thein HH, Amin J, Gidding HF, Ward K, Law GM, at al. Trends in mortality after diagnosis of hepatitis B or C infection:1992–2006. J Hepatol. 2011; 54: 879-86. Epub 2010 Oct 23
  4. Nelson KP, Mathers MB, Cowie B, Hagan H, Jarlais DD, Horyniak D, at al. Lancet. 2011; 378: 571-83. Epub 2011 Jul 27
  5. Torresi J, Johnson D, Wedemeyer H. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol. 2011; 54: 1273-85. Epub 2011 Jan 12
  6. Jacobsen HK, Wiersma TS. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28: 6653-7. Epub 2010 Aug 17
  7. Kara İH. Akut Viral Hepatit A. Türk Aile Hek Derg. 2007; 11: 177-84
  8. Eissa SA, Megid LMA, Ebeid SM, El-Naga SAA, Fath MDE. Prevalance of anti-HIV, HbsAg and anti-HCV reactivity in different categories of Egyptian blood donors: Experience of the National Cancer Institute in the last 5 years. Journal of the Egyptian Nat. Cancer Inst. 2002; 14: 217-21
  9. Girard MP, Osmanov S, Assossou OM, Kieny MP. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review. Vaccine. 2011; 29: 6191-218. Epub 2011 Jun 28
  10. Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton). 2010; 15: 137-45
  11. Evirgen Ö, Önlen Y, Köksaldı Motor V, Mahsereci E, İnci M, Şahin Ş. Hatay İli Hemodiyaliz Hastalarında HBV, HCV Seroprevalansı ve hepatit B Aşılaması ile oluşan antikor cevabının değerlendirilmesi. Viral Hepatit Derg. 2010; 16: 57-63
  12. Mıstık R. Türkiye'de viral hepatit epidemiyolojisi yayınların irdelenmesi. Tabak F, Balık İ, Tekeli E (eds). Viral Hepatit 2007
  13. Baskı. İstanbul: Viral Hepatitle Savaşım Derneği, 2007: 10-50
  14. Tekay F. Hakkari ilinde HBV, HCV ve HIV seroprevalansı. Dicle Tıp Dergisi. 2006; 33: 170-3
  15. Akçam FZ. Hepatit B Virüsü Enfeksiyonu. Sürekli Tıp Eğitimi Derg. 2003; 12: 211-4
  16. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevelance of hepatitis B infection in the Southeastern region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis. 2005; 58: 15-9
  17. Özdemir D, Kurt H. Hepatit B Virusu Enfeksiyonlarının Epidemiyolojisi. Taba